Oncolytics voluntarily delists common shares from Toronto Stock Exchange

Oncolytics (ONCY) Biotech announced that the common shares in the capital of the company will be voluntarily delisted from the Toronto Stock Exchange at the close of markets on August 22, 2025, pursuant to the company’s application for voluntary delisting and the satisfaction of the conditions to delist from the TSX. The delisting from the TSX will not affect the company’s listing on the Nasdaq. After delisting from the TSX, the shares will continue to trade on the Nasdaq under the symbol “ONCY.”